Status:
RECRUITING
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Lead Sponsor:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions:
Inherited Disease
Rare Diseases
Eligibility:
All Genders
18+ years
Brief Summary
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the...
Detailed Description
The study provides a collection of retrospective data from adult patients with ultra-rare inherited neurological diseases followed at "Carlo Besta" Neurological Institute from 1st January 2004 until M...
Eligibility Criteria
Inclusion
- Age \>= 18 years
- Subjects with ultra-rare inherited degenerative and metabolic neurological diseases
- Subjects with undiagnosed neurological diseases (when supposed to be inherited)
Exclusion
- none
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2031
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04880356
Start Date
March 1 2021
End Date
March 1 2031
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Milano, Italy, 20133